MT overexpression is associated with chemoresistance in patients receiving adjuvant therapy after surgery and promotes breast cancer cell invasion by increasing the expression of matrix metalloproteinase-9 (MMP9) [45,46]. This evidence concerns the gene MMP9 and breast cancer.